Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer: a Retrospective, Multicenter Trial

The Central Hospital of Lishui City0 sites80 target enrollmentMarch 12, 2022

ConditionsCentral Lung Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Central Lung Cancer
Sponsor: The Central Hospital of Lishui City
Enrollment: 80
Primary Endpoint: Formation of cavities in the central lung cancer, assessed up to 18 months.
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

This study is a retrospective, multicenter clinical study. The main goal is to identify the risk factors for cavity formation in central-type lung cancer lesions, and to construct a prediction model for cavity formation in central-type lung cancer lesions based on the above risk factors.

Registry

clinicaltrials.gov

Start Date

March 12, 2022

End Date

August 12, 2022

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

The Central Hospital of Lishui City

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age：older than 18 years；
•Clinical or pathologically confirmed central lung cancer;
•Lesions without cavities at first diagnosis of central lung cancer;
•Performed complete laboratory and imaging research at the first diagnosis of the central lung cancer;
•Patients with cavities formation during follow up, and the cavities were independently confirmed by at least 3 imaging experts;
•Patients with complete medical records;